HEPATIC FIBROSIS

Clinical trials for HEPATIC FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new HEPATIC FIBROSIS trials appear

Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

Vitamin B3 shows promise against fatty liver disease in new trial

Disease control Recruiting now

This study tests whether a daily dose of nicotinamide (a form of vitamin B3) can stop or reverse liver scarring (fibrosis) in people with fatty liver disease. Thirty overweight or obese adults with liver scarring will take either nicotinamide or a placebo for one year. Researcher…

Matched conditions: HEPATIC FIBROSIS

Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

HEPATIC FIBROSIS

Get alerted when new HEPATIC FIBROSIS trials appear

Vitamin B3 shows promise against fatty liver disease in new trial